Viewing Study NCT00944905


Ignite Creation Date: 2025-12-25 @ 3:29 AM
Ignite Modification Date: 2026-07-15 @ 4:04 PM
Study NCT ID: NCT00944905
Status: COMPLETED
Last Update Posted: 2013-05-22
First Post: 2009-07-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)
Sponsor: Bristol-Myers Squibb
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Carcinoma View
None Non-hodgkin's Lymphoma View
Keywords: